Pulmonx
LUNG
Pulmonx (LUNG) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.24
- EPS estimate
- −$0.25
- EPS surprise
- +4.00%
- Revenue surprise
- +0.16%
- Revenue
- $22.8M
- Revenue estimate
- $22.7M
- Reported
- Jul 29, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | −$0.25 | −$0.24 | +4.00% | $22.8M | SEC |
| Q1 2026 | Apr 29, 2026 | −$0.33 | −$0.33 | −1.01% | $20.6M | SEC |
| Q4 2025 | Mar 4, 2026 | −$0.39 | −$0.25 | +35.06% | $22.6M | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.42 | −$0.34 | +19.43% | $21.5M | SEC |
| Q2 2025 | Jul 30, 2025 | −$0.39 | −$0.38 | +3.60% | $23.9M | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.40 | −$0.36 | +9.98% | $22.5M | SEC |
| Q4 2024 | Feb 19, 2025 | −$0.45 | −$0.33 | +26.26% | $23.8M | SEC |
| Q3 2024 | Oct 30, 2024 | −$0.45 | −$0.36 | +19.73% | $20.4M | SEC |
| Q2 2024 | Jul 31, 2024 | −$0.42 | −$0.39 | +8.08% | $20.8M | SEC |
| Q1 2024 | May 1, 2024 | −$0.47 | −$0.36 | +23.32% | $18.9M | SEC |
| Q4 2023 | Feb 21, 2024 | −$0.41 | −$0.36 | +11.94% | $19.3M | SEC |
| Q3 2023 | Oct 30, 2023 | −$0.43 | −$0.39 | +8.86% | $17.7M | SEC |
| Q2 2023 | Aug 2, 2023 | −$0.44 | −$0.43 | +1.44% | $17.2M | SEC |
| Q1 2023 | May 2, 2023 | −$0.44 | −$0.42 | +4.55% | $14.5M | SEC |
| Q4 2022 | Feb 22, 2023 | −$0.42 | −$0.38 | +8.74% | $15.4M | SEC |
| Q3 2022 | Nov 3, 2022 | −$0.40 | −$0.38 | +4.19% | $13.5M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.41 | −$0.40 | +2.39% | $13.9M | SEC |
| Q1 2022 | May 3, 2022 | −$0.37 | −$0.43 | −15.84% | $10.8M | SEC |
| Q4 2021 | Feb 23, 2022 | −$0.36 | −$0.35 | +2.89% | $13.7M | SEC |
| Q3 2021 | Nov 2, 2021 | −$0.37 | −$0.28 | +24.77% | $13.3M | SEC |
Quarterly revenue
Frequently asked questions
When did Pulmonx (LUNG) last report earnings?
Pulmonx last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did LUNG beat earnings estimates?
Yes. Pulmonx reported EPS of −$0.24 for Q2 2026 against a −$0.25 estimate — a 4.00% beat.
How much revenue did LUNG report last quarter?
Pulmonx reported $22.8M in revenue for Q2 2026, against a consensus estimate of $22.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.